Prognostic and predictively relevant factors for multiple sclerosis

The immunotherapy of multiple sclerosis (MS) is currently one of the most dynamic fields in clinical neurology. The comprehensive number of well-established and new innovative treatment options are a challenge for an intensive preoccupation with the differential indications and an activity-driven tr...

Full description

Saved in:
Bibliographic Details
Published in:Nervenarzt 2014-10, Vol.85 (10), p.1255
Main Authors: Tackenberg, B, Schneider-Hohendorf, T, Müller, A, Schodrowski, J, Wiendl, H
Format: Article
Language:ger
Subjects:
Humans
Immunotherapy - methods
Incidence
Multiple Sclerosis - diagnosis
Multiple Sclerosis - epidemiology
Multiple Sclerosis - therapy
Prognosis
Risk Assessment - methods
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The immunotherapy of multiple sclerosis (MS) is currently one of the most dynamic fields in clinical neurology. The comprehensive number of well-established and new innovative treatment options are a challenge for an intensive preoccupation with the differential indications and an activity-driven treatment control. In this context this review summarizes the known predictors of the natural course of MS and gives a review of challenges to be expected in association with predictors of treatment control.
ISSN:1433-0407
DOI:10.1007/s00115-014-4062-2